We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.36%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.8B
AUM Growth
-$2.48B
(-5%)
Cap. Flow
-$831M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$130M |
| 2 |
Amgen
AMGN
|
+$96.1M |
| 3 |
Progressive
PGR
|
+$94.9M |
| 4 |
AbbVie
ABBV
|
+$77.1M |
| 5 |
Kenvue
KVUE
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$148M |
| 2 |
Johnson & Johnson
JNJ
|
+$147M |
| 3 |
LyondellBasell Industries
LYB
|
+$108M |
| 4 |
Dollar General
DG
|
+$91.2M |
| 5 |
ExxonMobil
XOM
|
+$87.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.48% |
| 2 | Healthcare | 17.42% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Phinia Inc
PHIN
$2.91B
| $327K | ﹤0.01% |
+12,210
| New | +$338K |
|
1677
Novavax
NVAX
$1.23B
| $323K | ﹤0.01% |
+44,650
| New | +$357K |
|
1678
Vanda Pharmaceuticals
VNDA
$314M
| $323K | ﹤0.01% |
74,760
| – | – |
|
|
TBI
1679
Trueblue
TBI
$237M
| $320K | ﹤0.01% |
21,803
| – | – |
|
|
HSII
1680
DELISTED
Heidrick & Struggles
HSII
| $319K | ﹤0.01% |
12,750
| – | – |
|
1681
QuinStreet
QNST
$893M
| $315K | ﹤0.01% |
35,170
| – | – |
|
1682
Digital Turbine
APPS
$1.04B
| $312K | ﹤0.01% |
51,620
| – | – |
|
1683
AdaptHealth
AHCO
$1.49B
| $311K | ﹤0.01% |
34,210
| – | – |
|
1684
MarineMax
HZO
$799M
| $309K | ﹤0.01% |
9,427
-573
| -6% | -$19.9K |
|
1685
TSMC
TSM
$2.07T
| $307K | ﹤0.01% |
3,538
-219
| -6% | -$20.7K |
|
|
WRK
1686
DELISTED
WestRock Company
WRK
| $307K | ﹤0.01% |
8,567
-84,435
| -91% | -$2.77M |
|
|
OSG
1687
Octave Specialty Group
OSG
$258M
| $306K | ﹤0.01% |
25,350
| – | – |
|
1688
RE/MAX Holdings
RMAX
$207M
| $305K | ﹤0.01% |
23,533
| – | – |
|
1689
Anika Therapeutics
ANIK
$200M
| $304K | ﹤0.01% |
16,300
| – | – |
|
|
BGFV
1690
DELISTED
Big 5 Sporting Goods
BGFV
| $304K | ﹤0.01% |
43,306
-2,696
| -6% | -$22.5K |
|
1691
Pliant Therapeutics
PLRX
$66.9M
| $303K | ﹤0.01% |
17,450
+150
| +0.9% | +$2.6K |
|
1692
Lightwave Logic
LWLG
$945M
| $298K | ﹤0.01% |
66,600
| – | – |
|
1693
Scholar Rock
SRRK
$5.86B
| $291K | ﹤0.01% |
40,940
+4,200
| +11% | +$28.2K |
|
1694
TKO Group
TKO
$13.7B
| $285K | ﹤0.01% |
+3,395
| New | +$315K |
|
1695
Kanzhun
BZ
$7.03B
| $284K | ﹤0.01% |
18,750
| – | – |
|
1696
Beyond Meat
BYND
$283M
| $281K | ﹤0.01% |
29,250
| – | – |
|
1697
Vir Biotechnology
VIR
$1.48B
| $281K | ﹤0.01% |
30,010
-147,691
| -83% | -$2.11M |
|
1698
TTEC Holdings
TTEC
$107M
| $279K | ﹤0.01% |
10,650
| – | – |
|
1699
Future Fuel
FF
$203M
| $276K | ﹤0.01% |
38,509
| – | – |
|
1700
Compañía de Minas Buenaventura
BVN
$8.06B
| $272K | ﹤0.01% |
31,950
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Ensign Peak Advisors held 1,786 positions worth $46.8B, down 5% from $49.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 3.1%. Ensign Peak Advisors opened 25 new positions and exited 30, leaving the 1,786-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2023 buy was Invesco QQQ Trust: 160,000 shares worth $57.3M.
- Ensign Peak Advisors added most to Crown Castle in Q3 2023, an estimated $130M increase.
- Ensign Peak Advisors's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $148M.
- Ensign Peak Advisors fully exited RB Global in Q3 2023, selling an estimated $26.5M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $46.8B portfolio in Q3 2023.
- Ensign Peak Advisors opened 25 new positions and closed 30 in Q3 2023.
- Ensign Peak Advisors's portfolio value fell 5% quarter-over-quarter to $46.8B.
Based on Ensign Peak Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.